|
|
||||||||||||||
|
|
|||||||||||||||
RESEARCH ETHICS |
Correspondence to:
Dr H Fangerau
Institute for the History of Medicine, Heinrich-Heine University Düsseldorf, Universitaetsstrasse 1, 40225 Düsseldorf, Germany; heiner.Fangerau{at}uni-duesseldorf.de
The aim of regenerative medicine is to reconstruct tissue that has been lost or pathologically altered. Therapeutic cloning seems to offer a method of achieving this aim; however, the ethical debate surrounding human therapeutic cloning is highly controversial. Artificial parthenogenesisobtaining embryos from unfertilised eggsseems to offer a way to sidestep these ethical pitfalls. Jacques Loeb (18591924), the founding father of artificial parthogenesis, faced negative public opinion when he published his research in 1899. His research, the publics response to his findings, and his ethical foundations serve as an historical argument both for the communication of science and compromise in biological research.
Keywords: artificial parthenogenesis; therapeutic cloning; regenerative medicine; ethics; history
This article has been cited by other articles:
![]() |
H M Fangerau The novel Arrowsmith, Paul de Kruif (1890-1971) and Jacques Loeb (1859-1924): a literary portrait of "medical science" Med. Humanit., December 1, 2006; 32(2): 82 - 87. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |